KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
72 hedge funds and large institutions have $177M invested in Kindred Biosciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
72
Holding in Top 10
1
Calls
$397K
Puts
–
Top Buyers
| 1 | +$4.25M | |
| 2 | +$1.98M | |
| 3 | +$1.2M | |
| 4 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$971K |
| 5 |
Goldman Sachs
New York
|
+$893K |
Top Sellers
| 1 | -$6.45M | |
| 2 | -$2.5M | |
| 3 | -$2.37M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$1.27M |
| 5 |
Millennium Management
New York
|
-$841K |